What is a cell line model?
Cell lines are in vitro model systems that are widely used in different fields of medical research, especially basic cancer research and drug discovery. Their usefulness is primarily linked to their ability to provide an indefinite source of biological material for experimental purposes.
What is cell line study?
Cell lines have revolutionized scientific research and are being used in vaccine production, testing drug metabolism and cytotoxicity, antibody production, study of gene function, generation of artificial tissues (e.g., artificial skin) and synthesis of biological compounds e.g., therapeutic proteins.
Where does TCGA data come from?
Data collection for TCGA began as a joint effort by the National Cancer Institute (NCI), National Human Genome Research Institute (NHGRI), National Institutes of Health (NIH), and the Department of Health and Human Services.
What is the difference between a cell and a cell line?
Primary cell culture is the culture of cells directly isolated from parental tissue of interest; whereas cell line is the culture of cells originated from a primary cell culture, which is generally used to expand cell population and prolong life span. However, cell lines have prolonged lifespan.
What are common cell lines?
Number 1: HeLa Shortly after establishment of this cell line, HeLa cells were used to proliferate the famous polio vaccine, and they continue to be the most widely used cell line in research labs worldwide.
What is the difference between cell line and cell culture?
Posted Jul 22, 2020. Primary cell culture is the culture of cells directly isolated from parental tissue of interest; whereas cell line is the culture of cells originated from a primary cell culture, which is generally used to expand cell population and prolong life span. However, cell lines have prolonged lifespan.
What does TCGA stand for?
The Cancer Genome Atlas (TCGA) is a project, begun in 2005, to catalogue genetic mutations responsible for cancer, using genome sequencing and bioinformatics.
